Medication info

Ezetimibe/Simvastatin Tablets 10/20

Prescription medicationTabletOralApproval withdrawn
Ingredient · strength
Ezetimibe›10mg / 1 tabletSimvastatin›20mg / 1 tablet
Manufacturer / importer
NBK Pharma Co., Ltd.
Appearance
White to pale white, biconvex, rectangular tablet
Packaging
30 tablets/PTP [(10 tablets/PTP X 3)]
Approval status
Approval withdrawn

MFDS item code 201906495 · Approved 2019.09.17

This product's status changed to Approval withdrawn on 2023.10.17. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of hypercholesterolemia (primary and homozygous familial) and mixed hyperlipidemia
Who takes it
Adults
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug. The dose of this drug should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. This drug is administered once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dosage range for this drug is 10/10mg~10/40mg once daily. The generally recommended initial dose is 10/20mg once daily. Patients who require a smaller reduction in LDL cholesterol may start with 10/10mg once daily. After starting treatment or adjusting the dose, adjust the dose after checking blood lipid levels at intervals of at least 4 weeks. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this drug should be used only in patients who have taken 10/80 mg of this drug for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This drug is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration to patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this drug is not recommended in patients with moderate or severe hepatic impairment (see 4. General Precautions, Patients with Abnormal Liver Function under Precautions for Use). Administration to patients with renal impairment and chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this drug once daily in the evening. If higher doses are administered to these patients, use caution and monitor them closely (see 4. General Precautions under Precautions for Use). Administration to elderly patients No dose adjustment is necessary in elderly patients. Concomitant administration with other drugs (See 5. Interactions under Precautions for Use.) This drug should be administered at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this drug concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this drug. Patients receiving this drug concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this drug.

Ingredients

Manufacturer
NBK Pharma Co., Ltd.

Efficacy & effects

Improvement of hypercholesterolemia (primary and homozygous familial) and mixed hyperlipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • atherosclerotic vascular disease due to hypercholesterolemia
  • dyslipidemia
  • diabetes
  • hypothyroidism
  • obstructive liver disease
  • chronic renal failure.
View approved original text

This medicine is used in conjunction with diet to lower total cholesterol, LDL cholesterol, ApoB protein, and triglycerides and to raise HDL cholesterol primarily in patients with primary hypercholesterolemia, familial and non-familial mixed hyperlipidemia. Additionally, it may be used alone in patients with homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatments or when other treatments are ineffective. This drug must be used safely in patients at high risk for atherosclerotic vascular disease due to hypercholesterolemia, considering multiple risk factors. Before administration, secondary causes of the disease should be identified and treated if necessary, and treatment decisions should be made based on lipid test results. This drug is used in conjunction with an appropriate diet that includes limiting saturated fats and cholesterol, and is administered when there is an inadequate response to diet or non-drug measures. This approach effectively improves the patient's lipid levels.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug. The dose of this drug should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. This drug is administered once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dosage range for this drug is 10/10mg~10/40mg once daily. The generally recommended initial dose is 10/20mg once daily. Patients who require a smaller reduction in LDL cholesterol may start with 10/10mg once daily. After starting treatment or adjusting the dose, adjust the dose after checking blood lipid levels at intervals of at least 4 weeks. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this drug should be used only in patients who have taken 10/80 mg of this drug for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This drug is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration to patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this drug is not recommended in patients with moderate or severe hepatic impairment (see 4. General Precautions, Patients with Abnormal Liver Function under Precautions for Use). Administration to patients with renal impairment and chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this drug once daily in the evening. If higher doses are administered to these patients, use caution and monitor them closely (see 4. General Precautions under Precautions for Use). Administration to elderly patients No dose adjustment is necessary in elderly patients. Concomitant administration with other drugs (See 5. Interactions under Precautions for Use.) This drug should be administered at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this drug concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this drug. Patients receiving this drug concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this drug.

Precautions

This medication has the potential to cause muscle disorders such as myopathy or rhabdomyolysis. The risk may be increased when taken in high doses or with certain medications, so caution is required. Patients with allergies to any ingredients in this medication or severe liver dysfunction, as well as pregnant or breastfeeding women, should not take this drug. Additionally, this medication can affect liver function, so patients with liver disease should always consult a doctor before taking it. If unexplained muscle pain or weakness occurs during use, it should be reported to a doctor immediately. This drug can interact with other medications, so patients should inform their healthcare providers of any other medications they are currently taking. Particularly, taking it with drugs that inhibit the enzymes that metabolize this drug in the liver may increase the risk of side effects. Women who are planning to become pregnant or are of childbearing potential should consult a doctor before taking this drug and stop the medication immediately if pregnancy is confirmed. During breastfeeding, as this drug may be excreted in breast milk, it is advised to discontinue breastfeeding. Caution is needed in elderly patients and children as safety and effectiveness have not been sufficiently confirmed. Regular blood tests to monitor liver function and muscle-related indicators are recommended. There is no specific antidote in case of overdose, and symptomatic treatment will be provided based on the symptoms. It is also safe to limit the intake of certain foods such as grapefruit juice while taking this drug.

Side effects

  • myopathy
  • rhabdomyolysis
  • elevated creatine kinase
  • headache
  • diarrhea
  • influenza
  • upper respiratory infection
  • myalgia
  • limb pain
  • fatigue
Show 88 more
  • abdominal pain
  • viral infection
  • pharyngitis
  • sinusitis
  • arthralgia
  • low back pain
  • cough
  • angioedema
  • rash
  • pancreatitis
  • nausea
  • cholelithiasis
  • cholecystitis
  • asthenia
  • cataracts
  • constipation
  • dyspepsia
  • flatulence
  • pruritus
  • eczema
  • rash
  • muscle cramps
  • immune-mediated necrotizing myopathy
  • taste disturbance
  • extraocular movement disorder
  • facial droop
  • tremor
  • dizziness
  • sensory disturbance
  • peripheral neuropathy
  • peripheral nerve paralysis
  • mental disorder
  • anxiety
  • sleep disorder
  • nightmares
  • depression
  • cognitive impairment
  • interstitial lung disease
  • anaphylaxis
  • lupus-like syndrome
  • polymyositis
  • dermatomyositis
  • vasculitis
  • purpura
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • antinuclear antibody positive
  • increased erythrocyte sedimentation rate
  • eosinophilia
  • arthritis
  • urticaria
  • photosensitivity
  • fever
  • chills
  • flushing
  • malaise
  • dyspnea
  • toxic epidermal necrolysis
  • Stevens-Johnson syndrome
  • alopecia
  • various skin changes
  • lichenoid drug eruption
  • gynecomastia
  • decreased libido
  • sexual dysfunction
  • ocular muscle paralysis
  • anemia
  • elevated aminotransferases
  • elevated ALP
  • elevated γ-GT
  • increased bilirubin levels
  • thyroid dysfunction
  • increased HbA1c
  • increased fasting blood glucose levels
  • edema
  • thirst
  • facial swelling
  • syncope
  • insomnia
  • gastritis
  • atrophic gastritis
  • mucous stools
  • irritable bowel syndrome
  • sore throat
  • nocturia
  • hematuria
  • weight loss

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored tightly sealed to prevent exposure to air or moisture. It is also safe to store at room temperature, that is, between 1 degree and 30 degrees Celsius, avoiding extreme heat or cold.

Appearance and packaging

Appearance

White to pale white, biconvex, rectangular tablet

Package unit

30 tablets/PTP [(10 tablets/PTP X 3)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.